The Influence of Probiotics in a Drinkable Yogurt on Skin Health

May 15, 2013 updated by: Nestlé

Phase 1 The Influence of Probiotics in a Drinkable Yogurt on Skin Health

The aim of this study is to test if probiotics administered to healthy female subjects in a dairy format have any skin health benefits.

Study Overview

Detailed Description

This is a placebo-controlled, double blind, randomized, single center, human clinical trial aimed at assessing the influence of probiotics on skin health in healthy female subjects, when administered in a food matrix over a period of 5 months.

It will consist of five groups(40 subjects/group). The first group (1) of subjects will receive acidified milk that does not contain bacterial strains. The second group (2) will receive acidified milk that contains one specific probiotic strain. The third group (3) will receive fermented milk that contains a standard mix of yogurt bacterial strains. The fourth group (4) will receive fermented milk, containing the same standard mix of yogurt bacterial strains as in group 3 plus the same specific probiotic strain as in group 2. Finally, the fifth group (5) will receive fermented milk, containing the same standard mix of yogurt bacterial strains as in group 3 and 4 plus the same specific probiotic strain as in group 2 and 4 plus a mix of antioxidants.

This study will address whether:

A.The bioefficacy of a specific probiotic strain is influenced by a milk matrix.

B.Whether other bacterial strains impact the bioefficacy of this specific probiotic strain, and validate whether or not the bioefficacy is related entirely to the activity of this specific probiotic strain.

C.Whether nutritional supplements impact the bioefficacy of a specific probiotic strain.

Study Type

Interventional

Enrollment (Actual)

207

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Düsseldorf, Germany, 40225
        • Institut für umweltmedizinische Forschung (IUF) an der Heinrich-Heine-Universität Düsseldorf gGmbH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Healthy women as assessed by medical history and standard medical examination
  • Caucasian
  • Age: 25-55 y (inclusive)
  • Normal BMI ≤ 30
  • Skin type 1-111
  • Regular Hormonal Cycle
  • Having given his/her written informed consent
  • Willing to avoid the consumption of fermented dairy products
  • Minimum consumption of dark chocolate during the period of the study

Exclusion Criteria:

  • Smoker
  • Pregnant or lactating women
  • Post menopausal women
  • Heavy alcohol intake (usually consuming more than 3 standard drinks/day)
  • Intake of chronic medications except oral contraceptive
  • Vitamin and/or mineral and/or antioxidant supplementation over the 3 months preceding the initiation of the study and throughout the study.
  • Having skin cancer or genetic disposition to skin cancer
  • Regular exposure to artificial UVR
  • Daily exposure to sun more than one week over the 2 months preceding the initiation of the study
  • Planned vacation to sun during the period of the study.
  • Excessive tea drinkers (more than 2 cups a day of green or black tea).
  • Excessive consumer of fermented dairy products (more than 150g per day).
  • Excessive consumer of dark chocolate (> 25g per day).
  • Regular high exercise such as a marathon
  • Subject who regularly takes saunas (dry or wet) or swims daily.
  • Subject who cannot be expected to comply with treatment
  • Currently participating or having participated in another interventional clinical trial during the last 3 months prior to the beginning of this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: 1
Glucono-Delta-Lactone acidified milk containing no bacterial strains
Glucono-Delta-Lactone acidified milk containing no bacterial strains
Experimental: 2
Glucono-Delta-Lactone acidified milk containing one probiotic strain called Lactobacillus paracasei NCC2461.
Glucono-Delta-Lactone acidified or fermented milk containing one probiotic strain.
Placebo Comparator: 3
Fermented milk containing two standard bacterial strains for acidification - Streptococcus thermophilus and Lactobacillus delbrueckii subsp.bulgaricus.
Fermented milk containing two standard yogurt bacterial strains.
Experimental: 4
Fermented milk containing two standard bacterial strains for acidification - Streptococcus thermophilus and Lactobacillus delbrueckii and one probiotic strain called Lactobacillus paracasei NCC2461.
Glucono-Delta-Lactone acidified or fermented milk containing one probiotic strain.
Fermented milk containing two standard yogurt bacterial strains.
Experimental: 5
Fermented milk containing two standard bacterial strains for acidification - Streptococcus thermophilus and Lactobacillus delbrueckii, one probiotic strain called Lactobacillus paracasei NCC2461 and Vitamin B2,B3, C and E, Beta Carotene and an Oil.
Glucono-Delta-Lactone acidified or fermented milk containing one probiotic strain.
Fermented milk containing two standard yogurt bacterial strains.
Fermented milk containing nutritional supplements

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Transepidermal water loss
Time Frame: baseline, 1 month, 2 months, 3 months, 5 months and 6 months
baseline, 1 month, 2 months, 3 months, 5 months and 6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Biopsy markers: transglutaminase, filagrin, involucrin, loricrin (mRNA)
Time Frame: baseline and at 5 months
baseline and at 5 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2009

Primary Completion (Actual)

April 1, 2010

Study Completion (Actual)

April 1, 2010

Study Registration Dates

First Submitted

March 13, 2009

First Submitted That Met QC Criteria

March 17, 2009

First Posted (Estimate)

March 18, 2009

Study Record Updates

Last Update Posted (Estimate)

May 16, 2013

Last Update Submitted That Met QC Criteria

May 15, 2013

Last Verified

September 1, 2009

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skin Health

Clinical Trials on no bacterial strains

Subscribe